Could a chemo pill boost immunotherapy for tough cancers?
NCT ID NCT05276284
First seen Jan 15, 2026 · Last updated May 23, 2026 · Updated 19 times
Summary
This early-phase trial tested whether adding thiopurine drugs (6-MP and 6-TG) to the immunotherapy atezolizumab could help shrink advanced solid tumors that have a moderate number of genetic mutations. The study enrolled 18 adults with metastatic cancers that had no standard cure. Researchers measured safety, side effects, and tumor response to find the best dose and see if the combination was effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR, ADULT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University Hospital of Copenhagen, Rigshospitalet
Copenhagen, 2100, Denmark
Conditions
Explore the condition pages connected to this study.